(Q42499365)

1 November 2017

Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells (English)

1 reference

1 November 2017

0 references

Dennis Ladage

1

1 reference

1 November 2017

Klara Brixius

2

1 reference

1 November 2017

Heike Hoyer

3

1 reference

1 November 2017

Caroline Steingen

4

1 reference

1 November 2017

Andreas Wesseling

5

1 reference

1 November 2017

Daniela Malan

6

1 reference

1 November 2017

Wilhelm Bloch

7

1 reference

1 November 2017

Robert H G Schwinger

8

1 reference

1 November 2017

1 August 2006

1 reference

Clinical and Experimental Pharmacology and Physiology

1 November 2017

1 reference

1 November 2017

33

1 reference

1 November 2017

8

1 reference

1 November 2017

720-724

1 reference

Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase

1 November 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04424.X

Nitric oxide mediated venodilator effects of nebivolol

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04424.X

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2006.04424.X

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/21224

10.1111/J.1440-1681.2006.04424.X

15 July 2023

Identifiers

DOI

1 reference

1 November 2017

1 reference